Method for stabilizing vertebral body architecture

A method for reducing the risk of new post-operative fractures in a patient's vertebrae after a vertebroplasty procedure to stabilize a fracture in a vertebra of the patient, the method comprising the steps of:

• performing a vertebroplasty procedure to stabilize a fracture in a vertebra of the patient, wherein the vertebroplasty procedure comprises the step of injecting a material into the fractured vertebra, wherein the material is formed by mixing together a first paste and a second paste, wherein the first paste comprises at least one of a polymerizable monomer and a filler, and wherein the second paste comprises at least one of a polymerizable monomer and a filler.

A method for reducing the risk of fractures in a patient's vertebrae and to alleviate pain after a vertebroplasty procedure performed to stabilize a fracture in a vertebra of the patient, the method comprising the steps of:

• performing a vertebroplasty procedure to stabilize a fracture in a vertebra of the patient, wherein the vertebroplasty procedure comprises the step of injecting a material into the fractured vertebra in an amount less than 3 cc, and allowing the material to harden for a period of 2.0-8.0 minutes to obtain heightened pain relief at about 3 months after the step of performing the vertebroplasty procedure;
• wherein the material is formed by mixing together a first paste and a second paste, wherein the first paste comprises at least one of a polymerizable monomer and a filler, and wherein the second paste comprises at least one of a polymerizable monomer and a filler.

A method for reducing the risk of fractures in a patient's vertebrae and to preserve physical functioning of the patient after a vertebroplasty procedure performed to stabilize a fracture in a vertebra of the patient, the method comprising the steps of:

• injecting a material into the fractured vertebra in an amount less than 3 cc, and allowing the material to harden for a period of 2.0-8.0 minutes to obtain better preservation of physical functioning of the patient at about 24 months after the step of injecting the material;
• wherein the material is formed by mixing together a first paste and a second pastes, wherein the first paste comprises at least one of a polymerizable monomer and a filler, and wherein the second paste comprises at least one of a polymerizable monomer and a filler.

A method for reducing the risk of fractures in a patient's adjacent vertebrae and simultaneously reducing the patient's exposure to implant material after a vertebroplasty procedure performed to stabilize a fracture in a vertebra of the patient, the method comprising the steps of:

• performing a vertebroplasty procedure to stabilize a fracture in a vertebra of the patient, wherein the vertebroplasty procedure comprises the step of injecting a material into the fractured vertebra in an amount less than 3 cc, and allowing the material to harden for a period of 2.0-8.0 minutes;
• wherein the material is formed by mixing together a first paste and a second paste to produce the material;
• and wherein the viscosity and flow characteristics of the material provide adequate fill of a given vertebral body volume and limit the volume of material leakage outside of the vertebral body thereby reducing the patient's exposure to implant material.

A method for reducing the risk of new post-operative fractures in an osteoporotic patient, the method comprising the steps of:

• injecting a bioactive material into the fractured vertebral body of a patient, wherein the bioactive material has a constant viscosity from about 100,000 to about 400,000 cP and allowing the bioactive material to flow and interdigitate into the vertebral body and bond to existing bone within the vertebral body thereby strengthening the vertebral body.

A method to stabilize a fractured vertebra of a patient, the method comprising the steps of:

• injecting a material into the fractured vertebra in an amount less than 3 cc, and allowing the material to harden, wherein the material achieves 100 percent of its strength capability as measured via maximum stress within 24 hours of the step of injecting the material thereby stabilizing the fractured vertebra and allowing the patient to bear weight.